Fumiaki Imamura1, Matthias B Schulze2, Stephen J Sharp1, Marcela Guevara3,4, Dora Romaguera5,6,7, Benedetta Bendinelli8, Elena Salamanca-Fernández4,9, Eva Ardanaz3,4, Larraitz Arriola10, Dagfinn Aune5,11,12, Heiner Boeing2, Courtney Dow13,14,15, Guy Fagherazzi13,14,15, Paul W Franks16,17, Heinz Freisling18, Paula Jakszyn19,20, Rudolf Kaaks21, Kay-Tee Khaw22, Tilman Kühn21, Francesca R Mancini13,14,15, Giovanna Masala8, Maria-Dolores Chirlaque4,23,24, Peter M Nilsson17, Kim Overvad25,26, Valeria M Pala27, Salvatore Panico28, Aurora Perez-Cornago29, Jose R Quirós30, Fulvio Ricceri31,32, Miguel Rodríguez-Barranco4,9, Olov Rolandsson16, Ivonne Sluijs33, Magdalena Stepien18, Annemieke M W Spijkerman34, Anne Tjønneland35, Tammy Y N Tong29, Rosario Tumino36, Linda E T Vissers33, Heather A Ward5, Claudia Langenberg1, Elio Riboli5, Nita G Forouhi1, Nick J Wareham1. 1. Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom. 2. Department of Molecular Epidemiology, Germen Institute of Human Nutrition, Potsdam, Germany. 3. IDISNA Navarra Health Research Institute, Pamplona, Spain. 4. CIBER Epidemiology and Public Health, Madrid, Spain. 5. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. 6. Health Research Institute of Balearic Islands (IdISBa), Palma de Mallorca, Spain. 7. CIBER Physiopathology of Obesity and Nutrition, Madrid, Spain. 8. Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy. 9. Andalusian School of Public Health, Institute of Investigation Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), University of Granada, Granada, Spain. 10. Public Health Division of Gipuzkoa, Instituto BIO-Donostia, Basque Government, CIBERESP, Gipuzkoa, Spain. 11. Department of Nutrition, Bjørknes University College, Oslo, Norway. 12. Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 13. Gustave Roussy Institute, Villejuif, France. 14. University Paris-South, Faculty of Medicine, University Versailles-St Quentin, University Paris-Saclay, Villejuif, France. 15. National Institute for Health and Medical Research (INSERM), Center for Research in Epidemiology and Population Health, Villejuif, France. 16. Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden. 17. Department of Clinical Sciences, Lund University, Skane University Hospital, Malmo, Sweden. 18. Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France. 19. Catalan Institute of Oncology, Barcelona, Spain. 20. FCS Blanquerna, Universitat Ramon Llull, Barcelona, Spain. 21. Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. 22. Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom. 23. Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain. 24. Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain. 25. Department of Cardiology, Aalborg University Hospital, Aarhus, Denmark. 26. Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark. 27. Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. 28. Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy. 29. Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. 30. Public Health Directorate, Asturias, Spain. 31. Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. 32. Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Italy. 33. Julius Center for Health Sciences and Primary Care, Cardiovascular Epidemiology, University Medical Center Utrecht, Utrecht, Netherlands. 34. National Institute for Public Health and the Environment, Bilthoven, Netherlands. 35. Danish Cancer Society Research Center, Copenhagen, Denmark. 36. Cancer Registry and Histopathology Department, "Civic-M.P. Arezzo" Hospital, Ragusa, Italy.
Abstract
INTRODUCTION: Beverage consumption is a modifiable risk factor for type 2 diabetes (T2D), but there is insufficient evidence to inform the suitability of substituting 1 type of beverage for another. OBJECTIVE: The aim of this study was to estimate the risk of T2D when consumption of sugar-sweetened beverages (SSBs) was replaced with consumption of fruit juice, milk, coffee, or tea. METHODS: In the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study of 8 European countries (n = 27,662, with 12,333 cases of incident T2D, 1992-2007), beverage consumption was estimated at baseline by dietary questionnaires. Using Prentice-weighted Cox regression adjusting for other beverages and potential confounders, we estimated associations of substituting 1 type of beverage for another on incident T2D. RESULTS: Mean ± SD of estimated consumption of SSB was 55 ± 105 g/d. Means ± SDs for the other beverages were as follows: fruit juice, 59 ± 101 g/d; milk, 209 ± 203 g/d; coffee, 381 ± 372 g/d; and tea, 152 ± 282 g/d. Substituting coffee for SSBs by 250 g/d was associated with a 21% lower incidence of T2D (95% CI: 12%, 29%). The rate difference was -12.0 (95% CI: -20.0, -5.0) per 10,000 person-years among adults consuming SSBs ≥250 g/d (absolute rate = 48.3/10,000). Substituting tea for SSBs was estimated to lower T2D incidence by 22% (95% CI: 15%, 28%) or -11.0 (95% CI: -20.0, -2.6) per 10,000 person-years, whereas substituting fruit juice or milk was estimated not to alter T2D risk significantly. CONCLUSIONS: These findings indicate a potential benefit of substituting coffee or tea for SSBs for the primary prevention of T2D and may help formulate public health recommendations on beverage consumption in different populations.
INTRODUCTION: Beverage consumption is a modifiable risk factor for type 2 diabetes (T2D), but there is insufficient evidence to inform the suitability of substituting 1 type of beverage for another. OBJECTIVE: The aim of this study was to estimate the risk of T2D when consumption of sugar-sweetened beverages (SSBs) was replaced with consumption of fruit juice, milk, coffee, or tea. METHODS: In the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study of 8 European countries (n = 27,662, with 12,333 cases of incident T2D, 1992-2007), beverage consumption was estimated at baseline by dietary questionnaires. Using Prentice-weighted Cox regression adjusting for other beverages and potential confounders, we estimated associations of substituting 1 type of beverage for another on incident T2D. RESULTS: Mean ± SD of estimated consumption of SSB was 55 ± 105 g/d. Means ± SDs for the other beverages were as follows: fruit juice, 59 ± 101 g/d; milk, 209 ± 203 g/d; coffee, 381 ± 372 g/d; and tea, 152 ± 282 g/d. Substituting coffee for SSBs by 250 g/d was associated with a 21% lower incidence of T2D (95% CI: 12%, 29%). The rate difference was -12.0 (95% CI: -20.0, -5.0) per 10,000 person-years among adults consuming SSBs ≥250 g/d (absolute rate = 48.3/10,000). Substituting tea for SSBs was estimated to lower T2D incidence by 22% (95% CI: 15%, 28%) or -11.0 (95% CI: -20.0, -2.6) per 10,000 person-years, whereas substituting fruit juice or milk was estimated not to alter T2D risk significantly. CONCLUSIONS: These findings indicate a potential benefit of substituting coffee or tea for SSBs for the primary prevention of T2D and may help formulate public health recommendations on beverage consumption in different populations.
Authors: Ivonne Sluijs; Nita G Forouhi; Joline W J Beulens; Yvonne T van der Schouw; Claudia Agnoli; Larraitz Arriola; Beverley Balkau; Aurelio Barricarte; Heiner Boeing; H Bas Bueno-de-Mesquita; Françoise Clavel-Chapelon; Francesca L Crowe; Blandine de Lauzon-Guillain; Dagmar Drogan; Paul W Franks; Diana Gavrila; Carlos Gonzalez; Jytte Halkjaer; Rudolf Kaaks; Aurelie Moskal; Peter Nilsson; Kim Overvad; Domenico Palli; Salvatore Panico; José R Quirós; Fulvio Ricceri; Sabina Rinaldi; Olov Rolandsson; Carlotta Sacerdote; María-José Sánchez; Nadia Slimani; Annemieke M W Spijkerman; Birgit Teucher; Anne Tjonneland; María-José Tormo; Rosario Tumino; Daphne L van der A; Stephen J Sharp; Claudia Langenberg; Edith J M Feskens; Elio Riboli; Nicholas J Wareham Journal: Am J Clin Nutr Date: 2012-07-03 Impact factor: 7.045
Authors: J W J Beulens; Y T van der Schouw; M M Bergmann; S Rohrmann; M B Schulze; B Buijsse; D E Grobbee; L Arriola; S Cauchi; M-J Tormo; N E Allen; D L van der A; B Balkau; H Boeing; F Clavel-Chapelon; B de Lauzon-Guillan; P Franks; P Froguel; C Gonzales; J Halkjaer; J M Huerta; R Kaaks; T J Key; K T Khaw; V Krogh; E Molina-Montes; P Nilsson; K Overvad; D Palli; S Panico; J Ramón Quirós; O Rolandsson; O Ronaldsson; I Romieu; D Romaguera; C Sacerdote; M-J Sánchez; A M W Spijkerman; B Teucher; A Tjonneland; R Tumino; S Sharp; N G Forouhi; C Langenberg; E J M Feskens; E Riboli; N J Wareham Journal: J Intern Med Date: 2012-05-08 Impact factor: 8.989
Authors: Dolly O Baliunas; Benjamin J Taylor; Hyacinth Irving; Michael Roerecke; Jayadeep Patra; Satya Mohapatra; Jürgen Rehm Journal: Diabetes Care Date: 2009-11 Impact factor: 17.152
Authors: Natasha Tasevska; Virag Sagi-Kiss; Susana A Palma-Duran; Brian Barrett; Matthew Chaloux; John Commins; Diane M O'Brien; Carol S Johnston; Douglas Midthune; Victor Kipnis; Laurence S Freedman Journal: Am J Clin Nutr Date: 2021-08-02 Impact factor: 8.472
Authors: C Wittenbecher; R Cuadrat; L Johnston; F Eichelmann; S Jäger; O Kuxhaus; M Prada; F Del Greco M; A A Hicks; P Hoffman; J Krumsiek; F B Hu; M B Schulze Journal: Nat Commun Date: 2022-02-17 Impact factor: 17.694
Authors: Tammy Y N Tong; Paul N Appleby; Timothy J Key; Christina C Dahm; Kim Overvad; Anja Olsen; Anne Tjønneland; Verena Katzke; Tilman Kühn; Heiner Boeing; Anna Karakatsani; Eleni Peppa; Antonia Trichopoulou; Elisabete Weiderpass; Giovanna Masala; Sara Grioni; Salvatore Panico; Rosario Tumino; Jolanda M A Boer; W M Monique Verschuren; J Ramón Quirós; Antonio Agudo; Miguel Rodríguez-Barranco; Liher Imaz; María-Dolores Chirlaque; Conchi Moreno-Iribas; Gunnar Engström; Emily Sonestedt; Marcus Lind; Julia Otten; Kay-Tee Khaw; Dagfinn Aune; Elio Riboli; Nicholas J Wareham; Fumiaki Imamura; Nita G Forouhi; Emanuele di Angelantonio; Angela M Wood; Adam S Butterworth; Aurora Perez-Cornago Journal: Eur Heart J Date: 2020-07-21 Impact factor: 35.855